Training academy Interface Aesthetics has launched a new polynucleotide training course across its sites in London and Manchester in partnership with aesthetic pharmaceutical company Croma Pharma.

Using the PhilArt polynucleotide range, the first course was held on February 17 and provided training from the Interface faculty of trainers, including director Mr James Olding.

Mr Olding commented, “Polynucleotides can be used in conjunction with other modalities in a synergistic way, with indications in areas of the face and neck that previously had limited treatment options. Without doubt, treatments focusing on cell health and regeneration are here to stay in 2024.” 

SOURCEAesthetics Journal
Previous articleAcorn Biolabs Appoints Crystal Muilenburg As Chief Commercial Officer
Next articleAllē by Allergan Aesthetics is the Leading Aesthetics Loyalty Rewards Program in the U.S.